Benlysta, Lösung zur subkutanen Injektion (Autoinjektor)

7680665850016 CH-66585 Lösung

Associated product:

BENLYSTA sol inj 200 mg/ml auto-injecteur 1 ml
Benlysta, Lösung zur subkutanen Injektion (Autoinjektor)
Benlysta, Lösung zur subkutanen Injektion (Autoinjektor)
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/08/2025
Patient information leaflet
Français
19/08/2025
Patient information leaflet
Italien
19/08/2025
Summary of Product Characteristics
Allemand
09/08/2025
Summary of Product Characteristics
Français
09/08/2025
Summary of Product Characteristics
Italien
09/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 263.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2019

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
66585
Drug name
Benlysta, Lösung zur subkutanen Injektion (Autoinjektor)
Galenic form
LSPA
ATC Code
L04AG04
Authorization status
Z
Dispensing category
B
First authorization
29/06/2018
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Systemischer Lupus erythematodes (SLE)

Package details

Description (FR)
BENLYSTA sol inj 200 mg/ml auto-injecteur 1 ml
Description (DE)
BENLYSTA Inj Lös 200 mg/ml Autoinjektor 1 ml
Market launch
29/06/2018
Narcotic (BTM)
No

Other package sizes (1)

BENLYSTA sol inj 200 mg/ml auto-injecteur 4 x 1 ml
4 INJ
GTIN: 7680665850023
View